Starlight Therapeutics, a wholly-owned subsidiary of Lantern Pharmaceuticals (NASDAQ: LTRN), formed to develop transformative ...

Boston Scientific Corporation will participate in the 2024 UBS Global Healthcare Conference on Tuesday, November 12, 2024.

Orsini has been chosen by Cycle Pharmaceuticals to distribute SAJAZIRtm (icatibant) Injection, a subcutaneous treatment for acute attacks of hereditary angioedema (HAE) in adults 18 years of age and ...

Third quarter 2024 total revenue grew 42% versus prior year to $139 million, including Crysvita® revenue of $98 million and Dojolvi® revenue of ...

The ROS-1 NSCLC current market is mainly dominated by tyrosine kinase inhibitors such as XALKORI at present and is ...

Western officials are investigating whether devices planted at shipping hubs in Europe may have been a test run by Russian operatives for placing them on planes bound for the U.S. By Michael ...

STAT Plus: Medicare Advantage insurers ramped up use of technology to deny claims, Senate investigation shows ...

Three gangsters entered a West Delhi showroom in broad daylight yesterday, gave the owner an extortion note with an amount written on it, fired multiple times in the air to drive home their ...

Canara Robeco Conservative Hybrid Fund (IDCW-M) 5.52 20,100 0.57 Canara Robeco Conservative Hybrid Fund-Dir (G) 5.52 20,100 0.57 Canara Robeco Conservative Hybrid ...

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 81,352.88 Crore) operating in Pharmaceuticals sector. Aurobindo Pharma Ltd. key Products/Revenue ...